Estrogen induced hypertriglyceridemia in an apolipoprotein AV deficient patient [1]

Journal of Internal Medicine

Volumn 263, Issue 1, 2008, Pages 107-108

  Henneman, P ^a   Schaap, F G ^b   Rensen, P C N ^a   Dijk, K W Van ^a   Smelt, A H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN A5; APOLIPOPROTEIN C3; ESTROGEN; FATTY ACID; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; GENETIC SUSCEPTIBILITY; HOMOZYGOSITY; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LETTER; ORAL CONTRACEPTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ADULT; APOLIPOPROTEINS A; DESOGESTREL; ETHINYL ESTRADIOL; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA;

EID: 36949030808     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2007.01889.x     Document Type: Letter

References (15)

1. Goldenberg NM, Wang P, Glueck CJ. An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia. Clin Chim Acta 2003 332 : 11 9.
2. Zorrilla E, Hulse M, Hernandez A, Gershberg H. Severe endogenous hypertriglyceridemia during treatment with estrogen and oral contraceptives. J Clin Endocrinol Metab 1968 28 : 1793 6.
3. Glueck CJ, Lang J, Hamer T, Tracy T. Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women. J Lab Clin Med 1994 123 : 59 4.
4. Glueck CJ, Gartside P, Fallat RW, Mendoza S. Effect of sex hormones on protamine inactivated and resistant postheparin plasma lipases. Metabolism 1976 25 : 625 32.
5. Brinton EA. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb Vasc Biol 1996 16 : 431 40.
6. O'Sullivan AJ, Ho KK. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women. J Clin Endocrinol Metab 1995 80 : 1783 8.
7. Perseghin G, Scifo P, Pagliato E et al. Gender factors affect fatty acids-induced insulin resistance in nonobese humans: effects of oral steroidal contraception. J Clin Endocrinol Metab 2001 86 : 3188 96.
8. Talmud PJ, Hawe E, Martin S et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 2002 11 : 3039 46.
9. Oliva CP, Pisciotta L, Li VG et al. Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia. Arterioscler Thromb Vasc Biol 2005 25 : 411 7.
10. Oliva CP, Tarugi P, Calandra S et al. A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia. Atherosclerosis 2006 188 : 215 7.
11. Ishihara M, Kujiraoka T, Iwasaki T et al. A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration. J Lipid Res 2005 46 : 2015 22.
12. Schaap FG, Nierman MC, Berbee JF et al. Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia. J Lipid Res 2006 47 : 2333 39.
13. Nalla VK, Rogan PK. Automated splicing mutation analysis by information theory. Hum Mutat 2005 25 : 334 42.
14. Henneman P, Schaap FG, Havekes LM et al. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism. Atherosclerosis 2007 193 : 129 34.
15. Talmud PJ. Rare APOA5 mutations-Clinical consequences, metabolic and functional effects An ENID review. Atherosclerosis 2007 194 : 287 92.